Results 271 to 279 of about 24,588 (279)

Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature

American Journal of Clinical Dermatology, 2018
Noa Kremer, Igor Snast, Emmilia Hodak
exaly  

Omalizumab

Reactions Weekly, 2010
openaire   +1 more source

Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Allergy: European Journal of Allergy and Clinical Immunology, 2005
exaly  

Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials

Journal of Allergy and Clinical Immunology, 2016
Zuo-tao Zhao, Tomasz Hawro, Marcus Maurer   +2 more
exaly  

Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria

Allergy: European Journal of Allergy and Clinical Immunology, 2017
exaly  

Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

New England Journal of Medicine, 2011
William Busse, Stephen J Teach, James F Chmiel   +2 more
exaly  

Omalizumab

Reactions Weekly, 2008
openaire   +1 more source

Omalizumab

Reactions Weekly, 2009
openaire   +1 more source

The effect of treatment with omalizumab, an anti‐IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma

Allergy: European Journal of Allergy and Clinical Immunology, 2005
exaly